# the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.

> **NCT02158559** · PHASE4 · UNKNOWN · sponsor: **Beijing Bozhiyin T&S Co., Ltd.** · enrollment: 180 (estimated)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DRUG:** Danhong Injection
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT02158559
- **Lead sponsor:** Beijing Bozhiyin T&S Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2015-12
- **Final completion:** —
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2014-06-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02158559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02158559, "the Effect of Danhong Injection on Microcirculation in the Treatment of Patients With STEMI After the PTCA Surgery.". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02158559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*